Propel Bio Management, LLC Top Holdings and 13F Report (2024) About Propel Bio Management, LLCInvestment ActivityPropel Bio Management, LLC has $172.41 million in total holdings as of September 30, 2024.Propel Bio Management, LLC owns shares of 21 different stocks, but just 8 companies or ETFs make up 80% of its holdings.Approximately 2.44% of the portfolio was purchased this quarter.About 7.78% of the portfolio was sold this quarter.This quarter, Propel Bio Management, LLC has purchased 24 new stocks and bought additional shares in 3 stocks.Propel Bio Management, LLC sold shares of 3 stocks and completely divested from 6 stocks this quarter.Largest Holdings Applied Therapeutics $55,826,793Plains GP $23,538,660Phathom Pharmaceuticals $15,728,280Achieve Life Sciences $11,627,656TScan Therapeutics $10,393,952 Largest New Holdings this Quarter Zevra Therapeutics $1,248,326 HoldingCOMPASS Pathways $504,000 HoldingMAAT PHARMA SACA $17,786 Holding Largest Purchases this Quarter Zevra Therapeutics 179,874 shares (about $1.25M)Ardelyx 146,364 shares (about $1.01M)Syndax Pharmaceuticals 50,000 shares (about $962.50K)COMPASS Pathways 80,000 shares (about $504K)Akero Therapeutics 15,977 shares (about $458.38K) Largest Sales this Quarter Abeona Therapeutics 624,022 shares (about $3.94M)Plains GP 100,000 shares (about $1.85M)Verrica Pharmaceuticals 80,000 shares (about $116.00K) Sector Allocation Over TimeMap of 500 Largest Holdings ofPropel Bio Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorAPLTApplied Therapeutics$55,826,7930.0%6,567,85832.4%MedicalPAGPPlains GP$23,538,660$1,850,000 ▼-7.3%1,272,36013.7%Oils/EnergyPHATPhathom Pharmaceuticals$15,728,2800.0%869,9279.1%MedicalACHVAchieve Life Sciences$11,627,6560.0%2,453,0926.7%MedicalTCRXTScan Therapeutics$10,393,9520.0%2,087,1396.0%MedicalAKROAkero Therapeutics$9,861,585$458,380 ▲4.9%343,7295.7%MedicalMDGLMadrigal Pharmaceuticals$9,132,2510.0%43,0325.3%MedicalRNAAvidity Biosciences$8,198,5050.0%178,5004.8%MedicalARDXArdelyx$7,378,825$1,008,448 ▲15.8%1,070,9474.3%MedicalTSATTelesat$4,817,3360.0%365,7812.8%Computer and TechnologyABEOAbeona Therapeutics$3,943,819$3,943,819 ▼-50.0%624,0222.3%MedicalKYMRKymera Therapeutics$2,667,4710.0%56,3591.5%MedicalSNDXSyndax Pharmaceuticals$2,565,236$962,500 ▲60.1%133,2591.5%MedicalKURAKura Oncology$2,540,2000.0%130,0001.5%MedicalZVRAZevra Therapeutics$1,248,326$1,248,326 ▲New Holding179,8740.7%MedicalEIGER BIOPHARMACEUTICALS$1,244,2390.0%146,3810.7%COMMATHAAthira Pharma$665,7850.0%1,492,7920.4%MedicalCMPSCOMPASS Pathways$504,000$504,000 ▲New Holding80,0000.3%MedicalVRCAVerrica Pharmaceuticals$500,159$116,000 ▼-18.8%344,9370.3%MedicalMAAT PHARMA SACA$17,786$17,786 ▲New Holding2,3970.0%COMMCHINOOK THERAPEUTICS$9,7500.0%79,3570.0%COMMFULCFulcrum Therapeutics$0$4,650,000 ▼-100.0%00.0%MedicalKYNKayne Anderson Energy Infrastructure Fund$0$1,518,851 ▼-100.0%00.0%Financial ServicesTRVITrevi Therapeutics$0$774,800 ▼-100.0%00.0%MedicalFIDELITY INV MMTRSY 1 680$0$317,014 ▼-100.0%00.0%COMMCYBIN INC$0$230,350 ▼-100.0%00.0%COMMMAAT PHARMA SACA$0$9,752 ▼-100.0%00.0%COMMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
